Therapeutic apheresis modalities, including therapeutic plasma exchange and extracorporeal photopheresis (ECP), are increasingly being utilized as part of the multidisciplinary care of solid organ transplant recipients. This session will compare and contrast different treatment regimens currently employed for preventing and treating solid organ transplant rejection. We will review the indications for initiating treatment with apheresis and the impact on patient outcomes. We will review the pathophysiology of organ rejection and more recent data on using ECP to induce organ tolerance. We will highlight ECP's role in managing chronic lung allograft rejection.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM23-TU-05-O: Use of Apheresis Modalities for the Management of Solid Organ Transplant Rejection (Enduring) Evaluation